Introduction {#s1}
============

Hematopoietic stem cells (HSCs) are at the foundation of the blood system and are the key cell type in transplantation protocols for blood-related disorders. The number of HSCs available for clinical applications and fundamental research is limited. The efficient expansion and/or generation *in vitro* is thus far not possible because our knowledge of the mechanisms underlying HSC growth, including the specific *in vivo* interactions between HSCs and the surrounding microenvironment are poorly understood.

Adult HSCs are generated only during a short window of developmental time ([@b1]). They are first detected at embryonic day (E)10.5 of mouse development in the Aorta--Gonad--Mesonephros (AGM) region ([@b20]; [@b23]). Starting at E11, HSCs are also found in the yolk sac (YS), placenta (PL) and fetal liver (FL). The pool of HSCs expands in the PL and FL before colonizing the bone marrow (BM) from E17 onward ([@b11]; [@b25]). Studies performed in the zebrafish, chicken and mouse models have clearly demonstrated that HSCs originate from specialized endothelial cells referred as hemogenic ([@b1]). HSCs most likely reside in clusters of cells (Intra-Aortic Hematopoietic Clusters, IAHCs) that are tightly attached to the endothelium of the aorta, the vitelline and umbilical arteries, and the vascular labyrinth of the placenta ([@b29]; [@b41]). In adult BM, HSCs localize in specialized niches that maintain the balance between HSC self-renewal, quiescence and differentiation. Adhesion molecules (including integrins) are important for the binding of HSCs to the BM niches ([@b13]; [@b24]; [@b26]; [@b28]; [@b38]; [@b40]). In contrast to adult, the specific interactions and cell adhesion properties of HSCs in the aorta and the successive developmental niches are as yet poorly described.

Integrins are transmembrane glycoproteins (gp) that play an important role in cell adhesion, survival, proliferation, differentiation, migration, gene regulation, and cytoskeletal arrangement. They are a family of 24 heterodimeric receptors composed of α (18 types) and β (8 types) subunits ([@b27]). While some integrins are ubiquitously expressed, others are tissue- or cell lineage-specific ([@b6]). Adult HSCs express several integrins important for homing and migration (e.g. α~4~β~1~, α~5~β~1~, α~6~β~1~) ([@b4]; [@b5]; [@b13]; [@b17]). In the embryo, α~IIb~ (platelet (gp)IIb or CD41) is one of the earliest surface markers of hematopoietic commitment ([@b9]; [@b10]; [@b19]; [@b21]; [@b22]; [@b33]) and its expression is developmentally regulated. E11 AGM HSCs express α~IIb~, whereas HSCs in the E12 AGM, E12 PL or E14 FL are α~IIb~ negative ([@b18]; [@b19]; [@b33]). By performing time-lapse confocal imaging on live mouse embryo slices, we have shown that the onset of α~IIb~ expression coincides with the formation of hematopoietic stem/progenitor cells (HSPCs) from the hemogenic aortic endothelium ([@b3]; [@b2]) and that α~IIb~ protein localizes at the point of contact between the cells in IAHCs.

To date little is known about integrin function and expression in HSCs throughout development. The BM of *α~IIb~* deficient mice show no hematopoietic lineage commitment problems ([@b37]) but possess defective platelets and display bleeding disorders similar to those seen in *β~3~* deficient mice ([@b15]) and humans with Glanzmann thrombasthenia disease. Here we examine the expression of α~IIb~, β~3~ and α~v~ integrin subunits on HSCs in the main hematopoietic sites (AGM, YS, PL, and FL) and the function of α~IIb~ in these cells. α~IIb~ exclusively associates with β~3~ to form the major platelet integrin α~IIb~β~3~ (gpIIb/IIIa or CD41/CD61). β~3~ also associates with α~v~ to form the α~v~β~3~ integrin (CD51/CD61). We show by performing *in vivo* transplantation assays of sorted populations that newly generated E11 AGM HSCs express α~IIb~β~3~ integrins whereas HSCs from E12 PL and E14 FL do not. α~v~β~3~ is expressed on all AGM and PL HSCs but on only a few E14 FL HSCs. All three types of HSCs were found in the E12 YS. Interestingly, *α~IIb~* deficient embryos show an HSC defect in the AGM but not in the YS and FL, indicating that α~IIb~ plays a fundamental and precise spatio-temporal role to maintain the HSC activity in the aorta of the mouse embryo.

Materials and Methods {#s2}
=====================

Mice and embryo generation {#s2a}
--------------------------

Embryos were generated from crosses of *hβ-globin ln72* mice and wild-type (C57BL/10×CBA)F1 females; Ly5.1 males and females; *α~IIb~^+/tk^* males and *α~IIb~^+/+^* or *α~IIb~^+/tk^* females; *α~IIb~^tk/tk^* males and *α~IIb~^+/+^* or *α~IIb~^+/tk^* females; wild-type C57BL/6 females and males. The day of vaginal plug observation is embryonic day (E)0. *ln72*, *YMT* and *α~IIb~* genotypes were determined by DNA PCR. Mice were housed according to institutional guidelines and all animal procedures were carried out in compliance with the Standards for human care and use of laboratory animals.

Dissections and cell preparation {#s2b}
--------------------------------

E11--E14 embryos were isolated. Tissues (AGM, FL, YS, PL) were dissected and dissociated as previously described ([@b31]). Viable cells were counted (using trypan blue) and kept in phosphate-buffered saline (PBS), 10% fetal calf serum, and penicillin/streptomycin (PBS/FCS/PS) at 4°C for further analysis.

Explant culture {#s2c}
---------------

Whole AGMs were cultured as explants at 37°C for 3 days as previously described ([@b20]). Explant cultures of *α~IIb~* mutant AGMs were performed with no added cytokines. To test the number of CD41^int^CD61^int^CD45^int^c-kit^+^ cells per wild-type AGM, the medium was supplemented or not with 200 ng/ml of recombinant murine IL-3 ([@b32]) or 250 ng/ml of gremlin ([@b8]).

Hematopoietic progenitor assay {#s2d}
------------------------------

*In vitro* hematopoietic progenitor analysis was performed on dilutions of sorted cells plated in triplicates in methylcellulose medium (StemCell Technologies). Plates were incubated at 37°C in a humidified chamber under 5% CO~2~. Hematopoietic colonies were counted with an inverted microscope at day 12 of the culture.

*In vivo* transplantation assay and transplanted mice analysis {#s2e}
--------------------------------------------------------------

Intravenous injection of total or sorted cells into irradiated adult wild-type recipients was as previously described ([@b32]). Recipient female mice ((129/SV×C57BL/6), C57BL/6 or (CBA×C57BL/10)) were exposed to a split dose of 9 Gy of γ-irradiation (^137^Cs source) and injected with several cell doses (or embryo equivalent, ee). 2×10^5^ spleen cells (recipient background) were co-injected to promote short-term survival.

Blood was obtained at 1 and 4 months post-transplantation and DNA was analyzed for donor cell markers by semiquantitative PCR (*hβ-globin, α~IIb~, Ymt*). The percentage of donor contribution was calculated from a standard curve of DNA control dilutions (0 to 100% donor marker). Recipients were considered repopulated when the chimerism was greater than 10%. For multilineage repopulation analysis, thymus, lymph nodes, bone marrow and spleen were dissected from the repopulated recipients. T, B, erythroid, and myeloid cells were sorted from recipient BM and spleens after antibody staining (see below). Primary recipient BM cells were injected into secondary irradiated recipients to assess self-renewal capacity (0.5×10^6^ or 2×10^6^ cells injected per recipient; [supplementary material Fig. S4D](http://bio.biologists.org/lookup/suppl/doi:10.1242/bio.20133715/-/DC1)). Chimerism level of the Ly5.2 recipients (C57BL/6) injected with Ly5.1 cells was determined by flow cytometry (see below). Recipients were considered repopulated when the chimerism was greater than 5%.

For statistical analysis, student\'s *t* test (Mann--Whitney) was used to determined statistical significance.

Flow cytometric analysis and sorting {#s2f}
------------------------------------

Flow cytometric analysis and sorting were performed on a FACScan and/or AriaIII (BD Bioscience) with CellQuest and FACSDiva. Stainings were performed in PBS/FCS/PS for 30 min at 4°C. Cells were washed and resuspended in PBS/FCS/PS and 7-AAD (Molecular Probes, Leiden, NL) or Hoechst 33258 (1 µg/ml, Molecular Probes) for dead cell exclusion. The positive gates were defined from staining with isotype-matched control antibodies. Monoclonal antibodies (BD Pharmingen, eBioscience, Invitrogen, Santa Cruz, Biolegends) used: FITC-anti-Ter119, FITC-anti-CD42c (Gp1bβ); PE-anti-CD41; APC-anti-CD61; FITC, APC-Cy7 or APC-AlexaFluor750-anti-c-kit; FITC, PE or PE-Cy7-anti-CD31; PerCP-Cy5.5-anti-CD45; APC or Pacific Blue-anti-CD34; Alexa-Fluor488-anti-CD51; Lin cocktail (PE-anti-Ter119, PE-anti-B220, PE-anti-Mac1, PE-anti-Gr1, PE-anti-CD3ε); PE-anti-CD48; APC-anti-CD150 and PE-Cy7-anti-Sca-1.

Ly5.2/Ly5.1 cell chimerism was determined by flow cytometry on blood after erythrocyte lysis (Beckman Coulter) and staining with FITC-anti-Ly5.2, PE-anti-Ly5.1 and 7-AAD. Flow cytometry data were analyzed with FlowJo.

For multilineage repopulation analysis, spleen cells were stained with FITC-anti-B220, PE-anti-CD8a and PE-anti-CD4; bone marrow cells were stained with FITC-anti-Ly6C and PE-anti-CD31.

Cell cycle analysis {#s2g}
-------------------

Cells from dissociated E11 AGM were stained with PE-anti-c-kit antibody. Cells were washed prior to fixation with 2% PFA for 30 min. Cells were then permeabilized for 1 h in 0.2% Triton X-100. After washing, cells were incubated during 1 h with FITC-anti-Ki-67 antibody or IgG isotype control. Cells were washed and incubated with Hoechst 33342 (1 µg/ml, Molecular Probes) prior to analysis by flow cytometry.

Pre-apoptosis analysis {#s2h}
----------------------

Cells from dissociated E11 AGM were stained with PE-anti-c-kit antibody. Cells were washed in cold PBS and resuspended in 1× binding buffer (10 mM Hepes/NaOH, pH 7.4, 140 mM NaCl, 2.5 mM CaCl~2~) and stained for 20 min with Annexin-V-FITC and Hoechst 33258 (1 µg/ml, Molecular Probes). Analyses were performed within 1 h by flow cytometry.

Whole-mount immunostaining {#s2i}
--------------------------

The whole-mount immunostaining was performed as previously described ([@b41]). Rat anti-mouse primary antibodies for c-Kit (2B8) and biotinylated anti-CD31 (MEC13.3) were used (BD Biosciences). Secondary antibodies were goat anti-rat IgG-Alexa647 (Invitrogen) and streptavidin-Alexa594 (Invitrogen). Embryo caudal halves were imaged using a Leica SP5 confocal microscope.

Staining and confocal microscopy of non-fixed embryo and placenta slices {#s2j}
------------------------------------------------------------------------

Non-fixed wild-type embryos were cut into thick transversal slices (200 µm) and stained with directly conjugated monoclonal antibodies as previously described ([@b3]; [@b2]). The antibodies include: PE-anti-CD41 (MWreg30), Alexa488-anti-CD51 (RMV-7), APC-anti-CD61. Similarly, placentas isolated from E12 non-fixed wild-type embryos were cut into slices (200 µm) and were incubated with PE-anti-Tie-2, Alexa488-anti-CD51 (RMV-7) and APC-anti-CD61. Slices were immobilized into agarose gel and imaged by using a Leica SP5 confocal microscope.

Results {#s3}
=======

Hematopoietic stem cells differentially express α~IIb~β~3~ and α~v~β~3~ integrins throughout development {#s3a}
--------------------------------------------------------------------------------------------------------

HSCs are restricted to the CD41^intermediate^ (CD41^int^) fraction in E11 AGM ([@b19]; [@b33]). However, HSCs in E12 AGM and PL, and E14 FL are exclusively in the CD41^−^ fraction. In YS, HSCs are in both populations ([@b33]). To further investigate integrin subunit expression on HSCs, we performed flow cytometric analyses for α~v~ (CD51) and β~3~ (CD61), in addition to α~IIb~ (CD41) expression. Cells were analysed at the time points corresponding to organ-specific peaks of HSC activity and subunit expression was found to differ between tissues ([Fig. 1](#f01){ref-type="fig"}). CD41^int^CD61^−^ cells were found only in E11 AGM ([Fig. 1A](#f01){ref-type="fig"}), and not in E12 YS ([Fig. 1C](#f01){ref-type="fig"}), E12 PL ([Fig. 1E](#f01){ref-type="fig"}) or E14 FL ([Fig. 1G](#f01){ref-type="fig"}). CD41^−^CD61^high^ cells were found mainly in E12 PL ([Fig. 1E](#f01){ref-type="fig"}) and to a lesser extent in E11 AGM ([Fig. 1A](#f01){ref-type="fig"}). Three distinct cell populations were present in all tissues: CD41^−^CD61^−^, CD41^−^CD61^int^ and CD41^int^CD61^int^.

![Phenotypic and functional analyses of integrin-based sorted cell fractions.\
(**A**,**C**,**E**,**G**) Flow cytometric analyses of E11 Aorta--Gonad--Mesonephros (AGM), E12 yolk sac (YS), E12 placenta (PL) and E14 fetal liver (FL). Representative sorting gates of each population are indicated. (**B**,**D**,**F**,**H**) Hematopoietic repopulation analyses after injection of integrin-based sorted fractions of AGM (*n* = 2), YS (*n* = 4), PL (*n* = 2) and FL (*n* = 3). Numbers above columns indicate number of mice repopulated/number of mice injected. Dose of injected cells is indicated as embryo equivalent (ee).](bio-02-05-525-f01){#f01}

To determine whether HSCs in E11 AGM expressed both α~IIb~ and β~3~ subunits, CD41^int^CD61^−^ and CD41^int^CD61^int^ fractions were sorted and injected into adult wild-type irradiated recipients (*n* = 2 (*n* = independent experiments when not specified otherwise)). Four months post-transplantation, the mice injected with CD41^int^CD61^int^ cells were reconstituted (5 mice reconstituted out of 6 mice transplanted, 5/6). No mice (0/8) injected with CD41^int^CD61^−^ cells were reconstituted, even with a high cell dose (3 ee per mouse) ([Fig. 1B](#f01){ref-type="fig"}). High-level multilineage engraftment of blood, BM, spleen, lymph nodes and thymus was found in the recipients receiving CD41^int^CD61^int^ cells ([supplementary material Fig. S1, top panel](http://bio.biologists.org/lookup/suppl/doi:10.1242/bio.20133715/-/DC1)) and secondary recipients were successfully engrafted with BM from these primary recipients, thus demonstrating that the CD41^int^CD61^int^ population contains bona fide HSCs ([supplementary material Fig. S1, bottom panel](http://bio.biologists.org/lookup/suppl/doi:10.1242/bio.20133715/-/DC1)). 95% of the CD41^int^CD61^int^ cells also expressed CD51 ([Table 1](#t01){ref-type="table"}). At E12, AGM HSCs were CD41^−^ ([@b33]) but still expressed CD51 ([Table 1](#t01){ref-type="table"}). Thus, all HSCs in E11 AGM express both α~IIb~β~3~ and α~v~β~3~ integrins.

###### Percentage of CD51^+^ cells in the cell fractions enriched in hematopoietic stem cells.

![](bio-02-05-525-t01)

YS HSCs are both CD41^−^ and CD41^int^ at E11 and E12 ([@b33]). In combination with CD61, three cell fractions were sorted from E12 YS (CD41^−^CD61^−^, CD41^−^CD61^int^ and CD41^int^CD61^int^) ([Fig. 1C](#f01){ref-type="fig"}) and transplanted (*n* = 4). Multilineage engraftment was obtained with all fractions ([Fig. 1D](#f01){ref-type="fig"}). Similar to E11 AGM HSCs, YS cells in the CD41^int^CD61^int^ and CD41^−^CD61^int^ fractions expressed CD51 (97% and 72% respectively) ([Table 1](#t01){ref-type="table"}). On the other hand, the majority of CD41^−^CD61^−^ cells did not express CD51 ([Table 1](#t01){ref-type="table"}). Thus, YS and AGM contain HSCs that express both α~IIb~β~3~ and α~v~β~3~ integrins, whereas some YS HSCs express solely α~v~β~3~ integrin or none of these integrins.

HSCs in PL and FL are CD41^−^ ([@b33]). CD41^−^CD61^−^, CD41^−^CD61^int^ and CD41^−^CD61^high^ (only present in PL) fractions were sorted ([Fig. 1E,G](#f01){ref-type="fig"}) and transplanted (PL: *n* = 2, FL: *n* = 3). The PL CD41^−^CD61^int^ fraction (but not the CD41^−^CD61^−^ fraction) contained HSCs ([Fig. 1F](#f01){ref-type="fig"}). Most of CD41^−^CD61^int^ cells expressed CD51 (86%) ([Table 1](#t01){ref-type="table"}). Thus, CD41^−^CD61^int^ HSCs in PL express only α~v~β~3~ integrin and therefore resemble CD41^−^CD61^int^ YS HSCs. In E14 FL, HSCs were in both CD41^−^CD61^−^ and CD41^−^CD61^int^ fractions ([Fig. 1H](#f01){ref-type="fig"}). Limiting cell dilution transplantations (0.001 to 0.1 ee) showed that HSCs were enriched in the CD41^−^CD61^−^ fraction ([Fig. 1H](#f01){ref-type="fig"}). Similar to E12 PL and YS, CD41^−^CD61^int^ FL cells also expressed CD51 (98%) ([Table 1](#t01){ref-type="table"}). In contrast, CD41^−^CD61^−^ FL cells did not express CD51 ([Table 1](#t01){ref-type="table"}). Thus, all HSCs in the PL express α~v~β~3~ but not α~IIb~β~3~ integrins, whereas most FL HSCs do not express these integrins.

E11 AGM hematopoietic stem cells are enriched in the CD41^int^CD61^int^CD45^int^c-kit^+^ subpopulation {#s3b}
------------------------------------------------------------------------------------------------------

Further enrichment of the E11 AGM CD41^int^CD61^int^ population was attempted with the pan-hematopoietic marker CD45 and the HSC marker c-kit ([@b35]). All committed cells from erythroid (Ter119^+^) and megakaryocytic (Gp1bβ^+^) lineages were first excluded ([supplementary material Fig. S2A, left panel](http://bio.biologists.org/lookup/suppl/doi:10.1242/bio.20133715/-/DC1)) and the CD41^int^CD61^int^ HSC containing fraction ([Fig. 1A,B](#f01){ref-type="fig"}) was sorted into four subfractions: CD45^−^c-kit^−^, CD45^−^c-kit^+^, CD45^int^c-kit^+^ and CD45^high^c-kit^+^ ([supplementary material Fig. S2A, middle and right panels](http://bio.biologists.org/lookup/suppl/doi:10.1242/bio.20133715/-/DC1)). Cells were injected into irradiated adult recipients and engraftment was measured at 1 month (short-term repopulation, STR) and 4 months (long-term repopulation, LTR) post-transplantation (*n* = 8). As expected, the CD45^−^c-kit^−^ and CD45^−^c-kit^+^ subfractions yielded no repopulation, even with high doses of injected cells (5--10 ee) ([supplementary material Fig. S2C](http://bio.biologists.org/lookup/suppl/doi:10.1242/bio.20133715/-/DC1)). The CD45^int^c-kit^+^ and CD45^high^c-kit^+^ subfractions yielded short-term repopulation ([supplementary material Fig. S2C, left panel](http://bio.biologists.org/lookup/suppl/doi:10.1242/bio.20133715/-/DC1)), but only the CD45^int^c-kit^+^ subfraction was capable of long-term repopulation ([supplementary material Fig. S2C, right panel](http://bio.biologists.org/lookup/suppl/doi:10.1242/bio.20133715/-/DC1)). These cells provided high-level multilineage reconstitution of the primary and secondary transplanted recipients ([supplementary material Fig. S2B](http://bio.biologists.org/lookup/suppl/doi:10.1242/bio.20133715/-/DC1)). Thus, the CD41^int^CD61^int^ population contains both STR-HSCs and LTR-HSCs that both express CD45 and c-kit. However, STR-HSCs and LTR-HSCs can be discriminated based on the level of CD45 expression: STR-HSCs are CD45^high^ while LTR-HSCs are CD45^int^. There is as few as 96±31 CD41^int^CD61^int^CD45^int^c-kit^+^ cells per E11 AGM (*n* = 6). Thus, the combination of integrin expression with other hematopoietic markers such as CD45 and c-kit can be used to discriminate cell populations highly enriched in STR-HSCs and LTR-HSCs in E11 AGM.

Interestingly, the number of CD41^int^CD61^int^CD45^int^c-kit^+^ cells per AGM was increased when E11 AGM explants were cultured in the presence of IL-3 and decreased in the presence of Gremlin, as compared to non-supplemented controls ([supplementary material Fig. S2D,E](http://bio.biologists.org/lookup/suppl/doi:10.1242/bio.20133715/-/DC1)). This is consistent with our previous findings that IL-3 is a powerful amplifying factor ([@b32]) and Gremlin (a BMP antagonist) is an inhibitory factor for HSC activity in E11 AGM ([@b8]; [@b30]). Therefore, the refined CD41^int^CD61^int^CD45^int^c-kit^+^ HSC phenotype provides a rapid readout for testing the effects of specific molecules/reagents in AGM and perhaps other embryonic culture systems.

Localization of α~IIb~, α~v~ and/or β~3~ integrin subunits expressing cells in the AGM and placenta {#s3c}
---------------------------------------------------------------------------------------------------

To determine the precise location of cells expressing α~IIb~, α~v~ and/or β~3~, multicolour stainings were performed using the technique that we previously developed to stain non-fixed embryo slices ([@b3]). We observed CD41^int^CD51^int^CD61^int^ cells in the IAHCs of E10.5 embryos ([Fig. 2A](#f02){ref-type="fig"}). Interestingly, the integrin subunits were concentrated at the junction between the IAHC cells.

![Location of phenotypically defined HSCs in AGM and placenta.\
(**A**) Intra-aortic hematopoietic clusters (IAHCs) of E10.5 wild-type embryos. Non-fixed embryo slices were stained with antibodies against CD51 (αv), CD41 (αIIb) and CD61 (β3). Scale bars: 10 µm. (**B**) Non-fixed placenta slices (E12) were stained with antibodies against Tie-2. Transmitted light and fluorescent images are merged. Scale bar: 100 µm. (**C**) Confocal stack image of an E12 non-fixed placenta slice stained with antibodies against CD51, CD61 and Tie-2. Close up of the boxed area (left panel) shows a group of labelled cells (single and merged fluorescent channels are shown). Scale bars: 10 µm. UA: umbilical artery, C: chorionic plate, L: labyrinth, S: spongiotrophoblast layer, FV: fetal vessel.](bio-02-05-525-f02){#f02}

The embryo slice staining technique was adapted to non-fixed PL. E12 PL slices stained with directly labelled anti-Tie-2 antibodies ([Fig. 2B](#f02){ref-type="fig"}) showed specific staining of both placental vessels and umbilical artery (UA). This allowed discrimination of the chorionic plate (C), the vascular labyrinth (L) and the spongiotrophoblast layer (S) ([Fig. 2B](#f02){ref-type="fig"}). To localize phenotypically defined HSCs in the Tie-2^+^ placental vessels (FV), multicolour staining was performed with anti-CD51 and CD61 antibodies ([Fig. 2C](#f02){ref-type="fig"}). Groups of CD51^int^CD61^int^ cells were observed in the vasculature of the chorionic plate and similar to the aorta, the integrin subunits were concentrated at the junctions between cells ([Fig. 2C](#f02){ref-type="fig"}). Thus, integrin expressing HSCs are localized in the IAHCs as well as in the vasculature of the placental chorionic plate.

*α~IIb~* deficient embryos have no qualitative or quantitative defects in AGM hematopoietic progenitors or IAHCs {#s3d}
----------------------------------------------------------------------------------------------------------------

All hematopoietic progenitors are CD41^int^ in the E11 AGM ([@b33]). To test whether α~IIb~ plays a role in the production of hematopoietic progenitors, AGM cells from E11 wild-type (*α~IIb~^+/+^*) and *α~IIb~* mutant (*α~IIb~^+/tk^* and *α~IIb~^tk/tk^*) embryos ([@b37]) were isolated and tested in the colony forming unit-culture assay (CFU-C; *n* = 3). As shown in [Fig. 3A](#f03){ref-type="fig"}, AGMs of E11 mutant embryos contained erythroid and myeloid progenitors. The numbers of total CFU-C and of each type of progenitor were similar in the mutants as compared to wild-type AGMs, demonstrating that α~IIb~ does not influence the production or function of AGM progenitors.

![Intra-aortic hematopoietic clusters and *in vitro* clonogenic progenitor activity of AGM cells isolated from E11 CD41 (***α~IIb~***) deficient embryos.\
(**A**) *In vitro* clonogenic analyses. AGMs were isolated from E11 wild-type (*α~IIb~^+/+^*), heterozygous (*α~IIb~^+/tk^*) or homozygous deficient embryos (*α~IIb~^tk/tk^*). Error bars: standard deviations for *n* = 3 independent experiments. CFU-GEMM: CFU-Granulocyte--Erythroid--Macrophage--Megakaryocyte; CFU-GM: CFU-Granulocyte--Macrophage; CFU-M: CFU-Macrophage; CFU-G: CFU-Granulocyte; BFU-E: Burst-Forming Unit-Erythroid. (**B**) Number of c-kit^+^ cells per E11 *α~IIb~^+/+^* (*n* = 5 embryos), *α~IIb~^+/tk^* (*n* = 5 embryos) and *α~IIb~^tk/tk^* (*n* = 3 embryos) aorta. Error bars: standard deviations. Confocal stack images of the mouse aorta region of E11 *α~IIb~^+/+^* (**C**) and *α~IIb~^tk/tk^* (**D**) embryos after whole mount staining for c-kit and CD31. Scale bars: 50 µm. ns: not statistically significant. Error bars: standard deviations.](bio-02-05-525-f03){#f03}

Whole embryo imaging of *α~IIb~^+/+^*, *α~IIb~^+/tk^* and *α~IIb~^tk/tk^* E11 embryos immunostained for CD31 (to visualize endothelial and IAHC cells) and c-kit (to visualize IAHC cells) revealed no differences in IAHC cell number ([Fig. 3B](#f03){ref-type="fig"}), organization or shape ([Fig. 3C,D](#f03){ref-type="fig"}). To investigate whether the lack of α~IIb~ affects the expression of α~v~ (CD51) and β~3~ (CD61), we performed flow cytometric analysis on *α~IIb~^+/+^*, *α~IIb~^+/tk^* and *α~IIb~^tk/tk^* E11 AGMs ([supplementary material Fig. S3](http://bio.biologists.org/lookup/suppl/doi:10.1242/bio.20133715/-/DC1)). CD51 and CD61 expression levels were similar between the different phenotypes, although the CD51^+^CD61^high^ population was absent in the *α~IIb~^tk/tk^* AGMs. Thus, the absence of CD41 does not influence expression of CD51 and CD61. Together, these results show that α~IIb~ is not needed for the formation, organization and anchorage of IAHCs, or there is functional redundancy with other integrins/adhesion molecules (e.g. α~v~β~3~).

*α~IIb~* deficient embryos have a hematopoietic stem cell defect in the AGM {#s3e}
---------------------------------------------------------------------------

To test whether α~IIb~ plays a role in the function of AGM HSCs, transplantations were performed with cells isolated from E11 wild-type (*α~IIb~^+/+^*) and *α~IIb~* mutant (*α~IIb~^+/tk^ and α~IIb~^tk/tk^*) AGMs (*n* = 3). Whereas 72% of the mice injected with *α~IIb~^+/+^* cells were reconstituted, only 29% and 38% of mice were reconstituted with *α~IIb~^+/tk^ or α~IIb~^tk/tk^* cells, respectively, at four months post-transplantation ([Fig. 4A](#f04){ref-type="fig"}). The percentage of donor cell chimerism was significantly lower in the few mice repopulated with *α~IIb~^+/tk^ or α~IIb~^tk/tk^* cells (10% average) as compared to the mice injected with *α~IIb~^+/+^* cells (60% average) ([Fig. 4A](#f04){ref-type="fig"}, red bars). The reconstitution with *α~IIb~^tk/tk^* cells resulted in multilineage engraftment ([supplementary material Fig. S4B,C](http://bio.biologists.org/lookup/suppl/doi:10.1242/bio.20133715/-/DC1)) similar to that found in mice reconstituted with *α~IIb~^+/+^* cells ([supplementary material Fig. S4A](http://bio.biologists.org/lookup/suppl/doi:10.1242/bio.20133715/-/DC1)). Secondary transplantations of BM cells (two cell doses, [supplementary material Fig. S4D,E](http://bio.biologists.org/lookup/suppl/doi:10.1242/bio.20133715/-/DC1)) isolated from two primary recipients repopulated with *α~IIb~^tk/tk^* AGM HSCs and one recipient repopulated with *α~IIb~^+/+^* cells ([Fig. 4A](#f04){ref-type="fig"}, red lozenges; [supplementary material Fig. S4A,B,C](http://bio.biologists.org/lookup/suppl/doi:10.1242/bio.20133715/-/DC1)) showed that *α~IIb~^tk/tk^* AGM HSCs were self-renewing. *α~IIb~^tk/tk^* AGM-derived cells successfully repopulated secondary recipients with similar chimerism as *α~IIb~*^+/+^ AGM-derived cells ([supplementary material Fig. S4D,E](http://bio.biologists.org/lookup/suppl/doi:10.1242/bio.20133715/-/DC1)). Thus, although *α~IIb~^+/tk^* and *α~IIb~^tk/tk^* embryos have fewer HSCs in the AGM as compared to *α~IIb~^+/+^* embryos, these are fully functional HSCs.

![Functional analyses of AGM, yolk sac and fetal liver cells isolated from E11 CD41 (*α~IIb~*) deficient embryos.\
Hematopoietic repopulation analysis of mice after injection of (**A**,**B**) AGM, (**C**) yolk sac or (**D**) fetal liver cells isolated from E11 wild-type (*α~IIb~^+/+^*), heterozygous (*α~IIb~^+/tk^*) or homozygous deficient embryos (*α~IIb~^tk/tk^*). (A,B) Percentage of chimerism in peripheral blood for each injected mice. Lozenge: one transplanted mouse. Red lozenge: mice used to perform secondary transplantations. Dashed line: limit of positivity (\>10% of chimerism). Red line: chimerism average. (A) AGM cells were injected directly (*n* = 3) or (B) after explant culture (*n* = 3). The genotype of embryos, the number of mice repopulated/number of mice transplanted (\# Rep./\# Inj.) and the percentage of repopulated mice (% Rep.) are indicated below the graphs. 1 embryo equivalent (ee) of AGM cells was injected per recipient (*n* = 3). p-values are indicated. (C,D) Percentage of repopulated mice. Numbers below columns: number of mice repopulated/number of mice transplanted. (C) 1 ee of yolk sac cells (*n* = 3) and (D) 3 to 4.5 ee of fetal liver cells (*n* = 4) were injected per recipient. Due to the very low number of HSCs in E11 FL, *α~IIb~^+/tk^* and *α~IIb~^tk/tk^* cells were pooled. ns: not statistically significant.](bio-02-05-525-f04){#f04}

It was previously shown that the number of HSCs increases when AGMs are cultured as explants for 3 days ([@b20]). We tested whether *α~IIb~* deficient HSCs can be maintained and expanded in AGM explant cultures (*n* = 3). Cells from *α~IIb~^+/tk^* or *α~IIb~^tk/tk^* AGM explants were able to reconstitute 13% and 20% of the transplanted recipients, as compared to 100% of recipients transplanted with cells from *α~IIb~^+/+^* AGM explants ([Fig. 4B](#f04){ref-type="fig"}). As expected the HSC repopulation ability of the *α~IIb~^+/+^* AGM cells was higher after explant culture, as compared to transplantations performed without pre-culture ([Fig. 4A](#f04){ref-type="fig"}). In contrast the HSC repopulation ability of the *α~IIb~* mutant AGM cells was significantly lower. This was not due to abnormal cycling or increased apoptosis of c-kit^+^ cells in the *α~IIb~* mutant AGM ([supplementary material Fig. S5A,B](http://bio.biologists.org/lookup/suppl/doi:10.1242/bio.20133715/-/DC1), respectively). Altogether, the results support a role for α~IIb~ in the maintenance of AGM HSC repopulating activity.

*α~IIb~* deficient embryos have no major hematopoietic stem cell defect in the YS or FL {#s3f}
---------------------------------------------------------------------------------------

HSC activity of *α~IIb~* mutant YSs was also tested (only some YS HSCs express α~IIb~). Transplantations with YS cells isolated from E11 *α~IIb~^+/+^*, *α~IIb~^+/tk^* and *α~IIb~^tk/tk^* embryos (*n* = 3) showed similar percentages of mice reconstituted (28%, 22% and 20%, respectively) at four months post-transplantation ([Fig. 4C](#f04){ref-type="fig"}). Thus, while there is a strong HSC defect in the AGM of the α*~IIb~* mutant embryos, it is not the case in the YS.

Similarly, we performed transplantations with FL cells isolated from E11 *α~IIb~^+/+^*, *α~IIb~^+/tk^* and *α~IIb~^tk/tk^* embryos (*n* = 4), at the time when HSCs start to colonize the FL. The percentage of reconstituted mice after the injection of *α~IIb~^+/tk^* or *α~IIb~^tk/tk^* cells (25%) was similar to the percentage of reconstituted mice after the injection of *α~IIb~^+/+^* cells (14%) ([Fig. 4D](#f04){ref-type="fig"}) thus showing that *α~IIb~* mutant HSCs are able to migrate and colonize the FL *in vivo*.

We further tested the HSC activity in the FL of *α~IIb~* mutant embryos at E14, a time point when HSCs extensively expand. Flow cytometry for Lin^−^Sca-1^+^c-kit^+^CD48^−^CD150^+^ cells showed that the absolute numbers of these phenotypically defined HSCs were similar in *α~IIb~* mutant embryos as compared to wild type ([supplementary material Fig. S6](http://bio.biologists.org/lookup/suppl/doi:10.1242/bio.20133715/-/DC1)). Limiting dilution transplantation of FL cells (0.001 \[*n* = 3\] and 0.005 \[*n* = 3\] ee per recipient) ([Fig. 5](#f05){ref-type="fig"}) showed that *α~IIb~* mutant FL cells were as competent as *α~IIb~^+/+^* FL cells in recipient reconstitution. Thus, HSCs have no proliferative defect in the FL of the *α~IIb~* mutant embryos.

![Functional analyses of E14 fetal liver cells isolated from CD41 (*α~IIb~*) deficient embryos.\
Hematopoietic repopulation analysis of mice after the injection of fetal liver cells isolated from E14 wild-type (*α~IIb~^+/+^*; grey bars), heterozygous (*α~IIb~^+/tk^*; dark grey bars), or homozygous deficient (*α~IIb~^tk/tk^*; black bars embryos. Numbers above columns: number of mice repopulated/number of mice transplanted.](bio-02-05-525-f05){#f05}

Discussion {#s4}
==========

The α~IIb~ integrin subunit (CD41) is one of the first surface markers indicative of hematopoietic commitment ([@b10]; [@b19]; [@b21]; [@b33]). It is notably expressed by the first hematopoietic cells emerging from the hemogenic endothelium in the aorta ([@b2]). We found here that α~IIb~ is not only a reliable HSC marker, but it also plays an important role in maintaining HSC activity in the aorta.

We have also found that HSCs differentially express α~IIb~, β~3~ and α~v~ integrin subunits during ontogeny. Since HSCs in embryos are difficult to identify *in situ*, integrin expression can be used in combination with other markers (as CD45 and c-kit) to enrich and localize HSCs throughout development. Surprisingly, a substantial fraction of HSCs in the E11/E12 YS do not express α~IIb~ and/or β~3~ integrin subunits. Such HSCs are not detectable in the AGM at the same time point, the YS might generate such a subset of HSCs. The results of *in vivo* CD41-Cre-mediated genetic tagging suggest that all/most HSCs go through an α~IIb~ expressing phase, as is reflected by a high percentage of labelled hematopoietic cells in the adult animals (35--65%) ([@b34]). Thus, the expression of integrins on the surface of HSCs appears to not only be regulated developmentally, but also by the surrounding cells that compose the HSC niches.

IAHC cells express α~IIb~ ([@b7]; [@b41]). Due to low expression levels, the visualization of CD41 by immunostaining embryo cryosections is rather difficult and often is in the context of high background. However, our results show that immunostaining of non-fixed embryo slices with directly conjugated antibodies allows the visualization of low level of integrin expression in the aorta with good resolution ([@b3]; [@b2]). We observed that IAHC cells co-express α~IIb~, β~3~ and α~v~. Interestingly, α~IIb~, β~3~ and α~v~ were mainly localized at the junction between the cells that form the IAHCs. Using this improved technique to immunostain viable PL slices, we were also able to observe the placental vasculature and groups of HSPCs expressing both α~v~ and β~3~ in the vasculature of the chorionic plate. Similar to the IAHCs, α~v~ and β~3~ were mainly at the junctions between the cells.

We have previously shown that hematopoietic progenitors in the E11 AGM and YS are CD41^int^, whereas they are in both CD41^−^ and CD41^int^ fractions in E12 PL and E14 FL ([@b33]). To test whether α~IIb~ plays a role in the progenitor activity in the AGM, we examined a mouse line (*α~IIb~^tk/tk^*) in which the *α~IIb~* locus was disrupted by the integration of a *tk* gene, resulting in the lack of α~IIb~ protein expression ([@b37]). We observed no differences in the total number or types of progenitors in the AGM of E11 *α~IIb~^+/+^*, *α~IIb~^+/tk^*, or *α~IIb~^tk/tk^* embryos. Such results indicate that α~IIb~ does not play a role in the regulation of the hematopoietic progenitors in the AGM region. This is in contrast to a study in which the disruption of α~IIb~ results in an increased number of hematopoietic progenitors (CFU-Myeloid, BFU-E and CFU-Mk) in E9.5 YS, and in E12.5, E13.5 and E15.5 FL ([@b9]). This difference in the requirement for α~IIb~ on progenitors might depend on the resident microenvironment. Thus, α~IIb~ does not play a functional role on the progenitors despite the fact that all progenitors express this marker in the AGM ([@b33]).

We observed fewer HSCs and a decrease in the HSC activity in the AGMs of *α~IIb~* mutant embryos. The few remaining HSCs were found to be functional in transplantation experiments, ruling out the possibility that *α~IIb~* mutant AGM HSCs are defective in homing to the adult BM niche. Interestingly, we did not find differences in the HSC activity in *α~IIb~* mutant YS and FL at the same time point of development (E11). The HSC activity was also normal at a later stage (E14), when HSC expansion occurs in the FL, indicating that *α~IIb~* mutant HSCs can undergo normal expansion. The HSC defect is thus restricted to the AGM region. The HSC activity was also lower after explant culture of the *α~IIb~* mutant AGMs showing that HSC activity is not maintained in the AGM when *α~IIb~* is absent. The defect seems to be cell intrinsic since only IAHC cells (where HSCs reside) express *α~IIb~* in the aorta at this stage of development. The observation that the HSC defect is similar in the AGMs in both *α~IIb~^+/tk^* and *α~IIb~^tk/tk^* embryos suggests that a certain threshold of α~IIb~ on the surface of HSCs might therefore be necessary to maintain the HSC activity in the AGM.

We found in *α~IIb~* mutant embryos that the number of c-kit^+^ IAHC cells and the shape of the IAHCs are similar to that in wild-type embryos. Thus, either α~IIb~ does not play a role in IAHC cell anchorage, or other adhesion molecules compensate for the absence of α~IIb~ (e.g. α~v~β~3~). The normal number of IAHCs also shows that α~IIb~, which is expressed by the emerging IAHCs and HSCs, is not required for the endothelial to hematopoietic transition (EHT).

Integrin binding to extra-cellular matrix compounds induces outside-in signaling through clustering of integrin heterodimers at focal adhesion sites ([@b12]; [@b16]). This will recruit other cell surface receptors and many proteins that will activate intracellular signaling pathways. Therefore, the absence of α~IIb~ might have direct or indirect consequences, resulting for example in the lack of recruitment of important receptors to the focal adhesion points (e.g. cytokine receptors) or the lack of signaling downstream of α~IIb~β~3~ integrins. It was shown that platelet clot formation is mediated through phosphorylation of the c-Src kinase (regulating downstream effectors such as RhoA) after binding of α~IIb~β~3~ to the Gα~13~ subunit ([@b12]). It was also recently shown that outside-in signaling via pY747 of β~3~ (β~3~PY747) following activation of α~v~β~3~ integrin by TPO-mediated inside-out signaling is indispensable for TPO-mediated maintenance of HSC activity *in vitro* and *in vivo* within the BM niche ([@b39]). Whether such mechanisms are also active on E11 AGM HSCs will be the focus of further investigations.

Altogether our study shows that β~3~ and α~v~ integrin subunits, in addition to α~IIb~, are reliable markers of the first HSCs found in the AGM. Such subunits are then differentially expressed by HSCs throughout embryonic development and can be used to isolate and localize HSCs. It has been shown that some integrin subunits are important for the retention of HSPCs in the adult BM niches (e.g. α~4~ ([@b36])) and/or for the colonization of HSPCs into the FL and BM (e.g. β~1~ ([@b14]; [@b26])). Here we highlight a new role for integrin subunits and provide evidence that α~IIb~ is important to maintain the HSC activity in the aorta.
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